Impairment of the retinoic acid-inducible gene-I-IFN-β signaling pathway in chronic hepatitis B virus infection

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1498-1504

  Zhao, Gangde ^a   An, Baoyan ^a   Zhou, Huijuan ^a   Wang, Hui ^a   Xu, Yumin ^a   Xiang, Xiaogang ^a   Dong, Zhixia ^a   An, Fangmei ^a   Yu, Dongshan ^a   Wang, Weijing ^a   Bao, Shisan ^b   Xie, Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Chronic hepatitis B; Dendritic cell; Innate immunity; Interferon; Retinoic acid inducible gene I

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BETA INTERFERON; CD14 ANTIGEN; CD86 ANTIGEN; MESSENGER RNA; RETINOIC ACID INDUCIBLE PROTEIN I; VIRUS DNA;

ACUTE HEPATITIS; ADULT; ARTICLE; CELL FUNCTION; CELL MATURATION; CELL STIMULATION; CELL STRAIN HEPG2; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS VIRUS; VIRAL CLEARANCE; VIRUS REPLICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; CASE-CONTROL STUDIES; DEAD-BOX RNA HELICASES; DENDRITIC CELLS; FEMALE; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; MALE; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VESICULOVIRUS;

EID: 84869479343     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1131     Document Type: Article

References (29)

1. Lok AS and McMahon BJ: Chronic hepatitis B: update 2009. Hepatology 50: 661-662, 2009.
2. Marinos G, Torre F, Chokshi S, et al: Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. Hepatology 22: 1040-1049, 1995.
3. Hatakeyama T, Noguchi C, Hiraga N, et al: Serum HBV RNA is a predictor of early emergence of the YMDD mutant in patients treated with lamivudine. Hepatology 45: 1179-1186, 2007. (Pubitemid 46775780)
4. Cheng G, Zhong J, Chung J and Chisari FV: Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci USA 104: 9035-9040, 2007. (Pubitemid 47175432)
5. Lee MS and Kim YJ: Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76: 447-480, 2007.
6. Hornung V, Ellegast J, Kim S, et al: 5'-Triphosphate RNA is the ligand for RIG-I. Science 314: 994-997, 2006.
7. Yoneyama M, Kikuchi M, Natsukawa T, et al: The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 5: 730-737, 2004. (Pubitemid 39023305)
8. Kato H, Sato S, Yoneyama M, et al: Cell type-specific involvement of RIG-I in antiviral response. Immunity 23: 19-28, 2005. (Pubitemid 41019654)
9. Fujita T, Onoguchi K, Onomoto K, Hirai R and Yoneyama M: Triggering antiviral response by RIG-I-related RNA helicases. Biochimie 89: 754-760, 2007. (Pubitemid 47001633)
10. Binder M, Kochs G, Bartenschlager R and Lohmann V: Hepatitis C virus escape from the interferon regulatory factor 3 pathway by a passive and active evasion strategy. Hepatology 46: 1365-1374, 2007. (Pubitemid 350155518)
11. Komuro A, Bamming D and Horvath CM: Negative regulation of cytoplasmic RNA-mediated antiviral signaling. Cytokine 43: 350-358, 2008.
12. Cai W, Xie Q, An B, et al: On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients. J Clin Virol 48: 22-26, 2010.
13. Lin LY, Wong VW, Zhou HJ, et al: Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients. J Med Virol 82: 1494-1500, 2010.
14. Dauer M, Obermaier B, Herten J, et al: Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 170: 4069-4076, 2003. (Pubitemid 36428169)
15. Nakhaei P, Mesplede T, Solis M, et al: The E3 ubiquitin ligase Triad3A negatively regulates the RIG-I/MAVS signaling pathway by targeting TRAF3 for degradation. PLoS Pathog 5: e1000650, 2009.
16. Sun D and Nassal M: Stable HepG2- and Huh7-based human hepatoma cell lines for efficient regulated expression of infectious hepatitis B virus. J Hepatol 45: 636-645, 2006. (Pubitemid 44466664)
17. tenOever BR, Sharma S, Zou W, et al: Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J Virol 78: 10636-10649, 2004. (Pubitemid 39258390)
18. Huang Q, Xie Q, Shi CC, et al: Expression of angiotensinconverting enzyme 2 in CCL4-induced rat liver fibrosis. Int J Mol Med 23: 717-723, 2009.
19. Jung MC and Pape GR: Immunology of hepatitis B infection. Lancet Infect Dis 2: 43-50, 2002.
20. Terhorst D, Kalali BN, Weidinger S, et al: Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands. Clin Exp Allergy 37: 381-390, 2007. (Pubitemid 46393237)
21. Patterson S, Donaghy H, Amjadi P, Gazzard B, Gotch F and Kelleher P: Human BDCA-1-positive blood dendritic cells differentiate into phenotypically distinct immature and mature populations in the absence of exogenous maturational stimuli: differentiation failure in HIV infection. J Immunol 174: 8200-8209, 2005. (Pubitemid 40806332)
22. Shimizu Y, Guidotti LG, Fowler P and Chisari FV: Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice. J Immunol 161: 4520-4529, 1998. (Pubitemid 28492022)
23. Randall RE and Goodbourn S: Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89: 1-47, 2008.
24. Hui CK and Lau GK: Immune system and hepatitis B virus infection. J Clin Virol 34: S44-S48, 2005.
25. Lin R, Lacoste J, Nakhaei P, et al: Dissociation of a MAVS/ IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage. J Virol 80: 6072-6083, 2006. (Pubitemid 43849185)
26. Asahina Y, Izumi N, Hirayama I, et al: Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 134: 1396-1405, 2008. (Pubitemid 351615363)
27. Stoop JN, van der Molen RG, Baan CC, et al: Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41: 771-778, 2005. (Pubitemid 40462939)
28. Zerbini A, Pilli M, Boni C, et al: The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 134: 1470-1481, 2008. (Pubitemid 351615362)
29. Chang JJ and Lewin SR: Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 85: 16-23, 2007. (Pubitemid 46067317)